MiNA Therapeutics Denmark ApS: Financial statements 2024
CVR: 43329545
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
MiNA Therapeutics Denmark ApS (CVR 43329545) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 4,727,426 and a net result of DKK 372,506 compared with DKK 6,623,979 the year before. That is a decrease of 58.3% compared with the year before. Equity in the 2024 report amounted to DKK 1,283,511. The solvency ratio was 21.1%. The company had 2 employees in the financial year.
- Gross Profit
- DKK 4,727,426
- Profit/Loss
- DKK 372,506
- Equity
- DKK 1,283,511
- Total Assets
- DKK 6,068,620
- Employees
- 2
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
MiNA Therapeutics Denmark ApS has published its annual report for 2023. Gross profit came to DKK 11,343,378, and the net result was DKK 6,623,979.
As of February 5, 2024, Troels Koch has stepped down as director of MiNA Therapeutics Denmark ApS.
As of February 5, 2024, Nagy Adly Habib has stepped down as director of MiNA Therapeutics Denmark ApS.
As of February 5, 2024, Peter James Jonathan Bains has stepped down as director of MiNA Therapeutics Denmark ApS.
About MiNA Therapeutics Denmark ApS
MiNA Therapeutics Denmark ApS was a Danish company of the type Anpartsselskab based in København SV, founded in 2022. The company has been dissolved on 28 May 2026. The company was registered under the industry Fremstilling af farmaceutiske præparater. The company has 2 employees (2025). In 2024, the company reported a gross profit of DKK 4,727,426 and a net result of DKK 372,506 compared with DKK 6,623,979 the year before. Equity in the 2024 report amounted to DKK 1,283,511.